These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 29113334)

  • 1. Exosomal miR-665 as a novel minimally invasive biomarker for hepatocellular carcinoma diagnosis and prognosis.
    Qu Z; Wu J; Wu J; Ji A; Qiang G; Jiang Y; Jiang C; Ding Y
    Oncotarget; 2017 Oct; 8(46):80666-80678. PubMed ID: 29113334
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emerging role of exosomal microRNA in liver cancer in the era of precision medicine; potential and challenges.
    El Hayek T; Alnaser-Almusa OA; Alsalameh SM; Alhalabi MT; Sabbah AN; Alshehri EA; Mir TA; Mani NK; Al-Kattan K; Chinnappan R; Yaqinuddin A
    Front Mol Biosci; 2024; 11():1381789. PubMed ID: 38993840
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exosomal miR-126 as a circulating biomarker in non-small-cell lung cancer regulating cancer progression.
    Grimolizzi F; Monaco F; Leoni F; Bracci M; Staffolani S; Bersaglieri C; Gaetani S; Valentino M; Amati M; Rubini C; Saccucci F; Neuzil J; Tomasetti M; Santarelli L
    Sci Rep; 2017 Nov; 7(1):15277. PubMed ID: 29127370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Usefulness of exosome-encapsulated microRNA-451a as a minimally invasive biomarker for prediction of recurrence and prognosis in pancreatic ductal adenocarcinoma.
    Takahasi K; Iinuma H; Wada K; Minezaki S; Kawamura S; Kainuma M; Ikeda Y; Shibuya M; Miura F; Sano K
    J Hepatobiliary Pancreat Sci; 2018 Feb; 25(2):155-161. PubMed ID: 29130611
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic and prognostic potential of serum microRNA-4651 for patients with hepatocellular carcinoma related to aflatoxin B1.
    Wu XM; Xi ZF; Liao P; Huang HD; Huang XY; Wang C; Ma Y; Xia Q; Yao JG; Long XD
    Oncotarget; 2017 Oct; 8(46):81235-81249. PubMed ID: 29113383
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreased levels of serum exosomal miR-638 predict poor prognosis in hepatocellular carcinoma.
    Shi M; Jiang Y; Yang L; Yan S; Wang YG; Lu XJ
    J Cell Biochem; 2018 Jun; 119(6):4711-4716. PubMed ID: 29278659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypoxia-induced exosomes promote hepatocellular carcinoma proliferation and metastasis via miR-1273f transfer.
    Yu Y; Min Z; Zhou Zhihang ; Linhong M; Tao R; Yan L; Song H
    Exp Cell Res; 2019 Dec; 385(1):111649. PubMed ID: 31562861
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor-derived exosomal miR-1247-3p induces cancer-associated fibroblast activation to foster lung metastasis of liver cancer.
    Fang T; Lv H; Lv G; Li T; Wang C; Han Q; Yu L; Su B; Guo L; Huang S; Cao D; Tang L; Tang S; Wu M; Yang W; Wang H
    Nat Commun; 2018 Jan; 9(1):191. PubMed ID: 29335551
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating exosomal noncoding RNAs as prognostic biomarkers in human hepatocellular carcinoma.
    Lee YR; Kim G; Tak WY; Jang SY; Kweon YO; Park JG; Lee HW; Han YS; Chun JM; Park SY; Hur K
    Int J Cancer; 2019 Mar; 144(6):1444-1452. PubMed ID: 30338850
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The utility of serum exosomal microRNAs in hepatocellular carcinoma.
    Jun L; Yang G; Zhisu L
    Biomed Pharmacother; 2019 Mar; 111():1221-1227. PubMed ID: 30841435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum exosomal microRNA-122 and microRNA-21 as predictive biomarkers in transarterial chemoembolization-treated hepatocellular carcinoma patients.
    Suehiro T; Miyaaki H; Kanda Y; Shibata H; Honda T; Ozawa E; Miuma S; Taura N; Nakao K
    Oncol Lett; 2018 Sep; 16(3):3267-3273. PubMed ID: 30127924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum exosomal microRNAs combined with alpha-fetoprotein as diagnostic markers of hepatocellular carcinoma.
    Wang Y; Zhang C; Zhang P; Guo G; Jiang T; Zhao X; Jiang J; Huang X; Tong H; Tian Y
    Cancer Med; 2018 May; 7(5):1670-1679. PubMed ID: 29573235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 14-3-3ζ delivered by hepatocellular carcinoma-derived exosomes impaired anti-tumor function of tumor-infiltrating T lymphocytes.
    Wang X; Shen H; Zhangyuan G; Huang R; Zhang W; He Q; Jin K; Zhuo H; Zhang Z; Wang J; Sun B; Lu X
    Cell Death Dis; 2018 Feb; 9(2):159. PubMed ID: 29415983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extracellular Vesicle-Related Non-Coding RNAs in Hepatocellular Carcinoma: An Overview.
    Augello G; Cusimano A; Cervello M; Cusimano A
    Cancers (Basel); 2024 Apr; 16(7):. PubMed ID: 38611093
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic potential of exosomal extracellular vesicles in oncology.
    Andre M; Caobi A; Miles JS; Vashist A; Ruiz MA; Raymond AD
    BMC Cancer; 2024 Mar; 24(1):322. PubMed ID: 38454346
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extracellular vesicles as tools and targets in therapy for diseases.
    Kumar MA; Baba SK; Sadida HQ; Marzooqi SA; Jerobin J; Altemani FH; Algehainy N; Alanazi MA; Abou-Samra AB; Kumar R; Al-Shabeeb Akil AS; Macha MA; Mir R; Bhat AA
    Signal Transduct Target Ther; 2024 Feb; 9(1):27. PubMed ID: 38311623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor-derived small extracellular vesicles in cancer invasion and metastasis: molecular mechanisms, and clinical significance.
    Zhang C; Qin C; Dewanjee S; Bhattacharya H; Chakraborty P; Jha NK; Gangopadhyay M; Jha SK; Liu Q
    Mol Cancer; 2024 Jan; 23(1):18. PubMed ID: 38243280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hsa-miR-665 Is a Promising Biomarker in Cancer Prognosis.
    Guan X; Pavani KC; Chunduru J; Broeckx BJG; Van Soom A; Peelman L
    Cancers (Basel); 2023 Oct; 15(20):. PubMed ID: 37894282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Emerging Role of Exosomal miRNAs as Biomarkers for Early Cancer Detection: A Comprehensive Literature Review.
    Jafari A; Karimabadi K; Rahimi A; Rostaminasab G; Khazaei M; Rezakhani L; Ahmadi Jouybari T
    Technol Cancer Res Treat; 2023; 22():15330338231205999. PubMed ID: 37817634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extracellular Vesicles in Hepatocellular Carcinoma: Progress and Challenges in the Translation from the Laboratory to Clinic.
    Yan R; Chen H; Selaru FM
    Medicina (Kaunas); 2023 Sep; 59(9):. PubMed ID: 37763719
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.